# Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

> **NCT06828757** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Hunan Province Tumor Hospital** · enrollment: 94 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** nanocrystalline megestrol oral suspension + PD-1/L1 inhibitor combined with chemotherapy
- **DRUG:** PD-1/L1 inhibitor combined with chemotherapy

## Key facts

- **NCT ID:** NCT06828757
- **Lead sponsor:** Hunan Province Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06828757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06828757, "Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06828757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*